We Are Servier
The downside of that is , in putting vaccine development and vaccine manufacturing over everything else , oncology medicines were deemed less essential during that period . Lemay had multiple conversations with past colleagues in the industry , where he was able to discuss the challenges and implications associated with prioritising COVID- 19 vaccines , especially for people living with cancer .
“ What ended up happening was that critical raw materials and components that we use in our manufacturing process were essentially being prioritised to the COVID-19 vaccine manufacturers .”
This just made the entire supply chain that much more difficult to manage than
“ MY ROLE IN THE SUPPLY CHAIN IS TO ENSURE THAT OUR PATIENTS NEVER MISS A TREATMENT ”
ERIC LEMAY HEAD OF GLOBAL EXTERNAL MANUFACTURING , SERVIER it already was , adding even more pressure onto healthcare services .
“ I think one of the other challenges for us was that one of our more important medicines used in paediatric oncology has a very short shelf life , sot ' s really justin-time manufacturing . We can ' t have safety stock throughout the supply chain . So , any last minute disruption has a direct impact on our ability to get the product to the patient . For example , if we can ' t get a raw material or a component , then it delays manufacturing . It ' s an extremely challenging product to manufacture and distribute .”
Servier is maintaining an agile , strong supply chain with their patients in mind , because , as a private company , it has a little bit more
100 July 2022